Homologous Desensitization of the D1Dopamine Receptor
- 1 December 1990
- journal article
- research article
- Published by Wiley in Journal of Neurochemistry
- Vol. 55 (6) , 2111-2116
- https://doi.org/10.1111/j.1471-4159.1990.tb05803.x
Abstract
Preincubation of D384 cells, derived from the human astrocytoma cell line G-CCM, with dopamine resulted in a time-dependent attenuation of cyclic AMP responsiveness to subsequent dopamine stimulation. This effect was agonist specific because the prostaglandin E1 (PGE,) stimulation of cyclic AMP of similarly treated cells remained unchanged. The attenuation by dopamine was concentration dependent with a maximum observed at 100 μM. A comparison of dopamine concentration-response curves of control and dopamine-preincubated cells revealed no change in the Ka apparent value, but a marked attenuation of the maximal response. Preincubation of cells with dopamine in the presence of D1 but not D2 selective antagonists partially prevented the observed attenuation. Attenuations in dopamine responsiveness were also obtained when D384 cells were preincubated with D1 but not D2 receptor agonists. The level of attenuation attained related to agonist efficiency in stimulating cyclic AMP: SKF38393 < 3,4-dihydroxynomifensine < fenoldopam < 2-amino-6,7-dihydroxy-1,2,3,4-tetrahydronaphthalene = dopamine. However, increasing the efficiency of 3,4-dihydroxynomifensine stimulation of cyclic AMP, using the synergistic effect of adding a low concentration of forskolin, produced no further change in the attenuation of the subsequent response to dopamine. Thus, the D1 dopamine receptors expressed by D384 cells undergo homologous desensitization. Uncoupling of the D1 dopamine receptor appears to be independent of cyclic AMP formation, analogous to a mechanism proposed for the β-adrenergic receptor.Keywords
This publication has 21 references indexed in Scilit:
- Characterization of Dopamine and β‐Adrenergic Receptors Linked to Cyclic AMP Formation in Intact Cells of the Clone D384 Derived from a Human AstrocytomaJournal of Neurochemistry, 1988
- Chronic treatment with dopamine receptor antagonists: behavioral and pharmacologic effects on D1 and D2 dopamine receptorsJournal of Neuroscience, 1988
- Regulation Of Adenylyl Cyclase-Coupled Beta-Adrenergic ReceptorsAnnual Review of Cell and Developmental Biology, 1988
- D‐1 Dopaminergic and β‐Adrenergic Stimulation of Adenylate Cyclase in a Clone Derived from the Human Astrocytoma Cell Line G‐CCMJournal of Neurochemistry, 1986
- Regulation of agonist and antagonist binding to striatal D-1 dopamine receptors: Studies using the selective D-1 antagonist [3H]SK&F R-83566Life Sciences, 1986
- Beta-adrenergic receptor kinase: identification of a novel protein kinase that phosphorylates the agonist-occupied form of the receptor.Proceedings of the National Academy of Sciences, 1986
- Forskolin Potentiates the Stimulation of Rat Striatal Adenylate Cyclase Mediated by D‐1 Dopamine Receptors, Guanine Nucleotides, and Sodium FluorideJournal of Neurochemistry, 1986
- Differential involvement of dopamine D-1 and D-2 receptors in the circling behaviour induced by apomorphine, SK & F 38393, pergolide and LY 171555 in 6-hydroxydopamine-lesioned ratsPsychopharmacology, 1985
- Functional alteration of the beta-adrenergic receptor during desensitization of mammalian adenylate cyclase by beta-agonists.Proceedings of the National Academy of Sciences, 1984
- Characterization of the binding of 3H-SCH 23390, a selective D-1 receptor antagonist ligand, in rat striatumLife Sciences, 1984